CliffBio
small molecule

GILENYA

FINGOLIMOD HYDROCHLORIDE

Loss of exclusivitySeptember 2032latest FDA-listed patent expiry
CompanyNovartis →View the full company profile on CliffBio

Drug detail

Brand nameGILENYA
Active ingredientFINGOLIMOD HYDROCHLORIDE
StrengthEQ 0.25MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2018
Marketing statusRX

Listed patents

PatentExpiresType
9592208*PEDSeptember 2032—
9592208March 2032product

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

GILENYA patent cliff — loss of exclusivity September 2032 | CliffBio